50 results
8-K
EX-3.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
the Corporation in writing as soon as practicable of any action, suit, proceeding or investigation involving such Indemnitee for which indemnity will or could … be sought. With respect to any action, suit, proceeding or investigation of which the Corporation is so notified, the Corporation will be entitled
424B3
GOSS
Gossamer Bio Inc
28 Aug 23
Prospectus supplement
4:29pm
or discounts or concessions allowed to such broker-dealer(s), where applicable, (v) that such broker-dealer(s) did not conduct any investigation
S-3
GOSS
Gossamer Bio Inc
18 Aug 23
Shelf registration
8:41am
) that such broker-dealer(s) did not conduct any investigation to verify the information set out or incorporated by reference in this prospectus, and (vi
S-3ASR
vmh4uqaosuy5qmthnqli
17 Aug 23
Automatic shelf registration
4:01pm
8-K
EX-10.1
3cmjw7xq1r9
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
S-3ASR
fp2ie3
9 Aug 22
Automatic shelf registration
12:00am
S-3ASR
EX-4.4
czl6op80
3 Mar 22
Automatic shelf registration
4:05pm
8-K
EX-1.2
46rlnd5ea e0
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-4.2
j0v4ukxdpjc9axvns
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.1
25ogjuv5n250 9tl6h2
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-4.1
47cfho8r e9ugkoytb8k
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm